Jump to content

Phetharbital

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DePiep (talk | contribs) at 20:06, 2 April 2016 (Remove redundant parameters InChI, InChIKey (StdInChI, StdInChIKey are used). See Talk (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Phetharbital
Clinical data
Other namesPhetharbital
ATC code
  • none
Identifiers
  • 1-phenyl-5,5-diethyl-1,3-diazinane-2,4,6-trione
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.006.015 Edit this at Wikidata
Chemical and physical data
FormulaC14H16N2O3
Molar mass260.288 g/mol g·mol−1
3D model (JSmol)
  • c2ccccc2N(C1=O)C(=O)NC(=O)C1(CC)CC
  • InChI=1S/C14H16N2O3/c1-3-14(4-2)11(17)15-13(19)16(12(14)18)10-8-6-5-7-9-10/h5-9H,3-4H2,1-2H3,(H,15,17,19) ☒N
  • Key:ILORKHQGIMGDFN-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Phetharbital (Phenetharbital) is a barbiturate derivative. It has anticonvulsant effects and relatively weak sedative action, and is considered to have a low abuse potential.[1]

References

  1. ^ Eddy NB, Halbach H, Isbell H, Seevers MH. Drug dependence: Its significance and characteristics. Bulletin of the World Health Organisation. 1965;32:721-733.



Stub icon

This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Phetharbital&oldid=713233995"